HKUMed uncovers T cell exhaustion factor driving cancer immunotherapy resistance
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
French biotech company Onxeo S.A. has given an update on the clinical development program of…
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared…
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats…
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
Atrogi AB, an early-stage Swedish pharma company, has announced that the first patient has been…
Sysnav Healthcare and Roche have partnered to develop industry standard outcome measurements in diseases associated…
Ibex Medical Analytics has announced an agreement with AstraZeneca and Daiichi Sankyo, for the development,…
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
Alcohol-related liver disease is among the most common causes of morbidity and mortality worldwide. Due…
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…